Thus, HGF, as a paracrine factor, may contribute to successful stem-cell-based therapies, which have been investigated in many clinical trials in the context of pathologies such as SCI, PD, ALS, AD, and MS with promising results ( Hepatocyte growth factor also acts on non-neural cells in the context of peripheral nerve regeneration, such as after a peripheral nerve injury
Keeping logs of any symptoms, their timing, and their resolution
Human subjects are required for clinical trials in order to evaluate safety, effectiveness, and any side effects
It is not approved for human consumption or therapeutic use in the UK
In the ageing population, the ability to absorb B12 often declines, which can affect energy levels and cognitive function